The Uterine Cancer Study Act of 2025 directs the federal government to investigate whether chemical hair straighteners increase the risk of uterine cancer, with particular attention to higher rates among women of color. The Department of Health and Human Services, working with the FDA and National Institutes of Health, will review existing research, examine the effects across different racial and ethnic groups, and analyze whether specific ingredients like dyes, bleach, or perms pose particular risks. The study must begin within 180 days of the bill's enactment and be completed within two years, with a detailed methodology submitted to Congress within 45 days. The final report will determine whether the FDA should require hair straightening product manufacturers to conduct additional safety testing before products reach consumers. No specific funding amount is mentioned in the legislation.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.